Responses
Clinical/translational cancer immunotherapy
Original research
Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio
Compose a Response to This Article
Other responses
No responses have been published for this article.
